FDA warns Chinese drug maker over lying
(By Ed Silverman for ST A T) T he next time that employees at Xiamen Origin Biotech want to lie
Read More
Part D/Prescription Drugs
In cancer, it’s back to the future as old treatments make cutting-edge ones more effective
(By Sharon Begley for ST A T) N ew cancer drugs that unleash the immune system on tumors are all
Read MoreUS researchers now testing Zika vaccines in human subjects
(By Andrew Joseph for ST A T) F ederal health researchers have started testing an experimental Zika vaccine in people,
Read MoreThere’s a possible cure for ‘bubble boy’ disease. It will cost $665,000
(By Damian Garde for ST A T) G laxoSmithKline has developed what looks like a cure for a rare and
Read MoreMost Californians support a measure to obtain state discounts on drugs
(By Ed Silverman for ST A T) T he pharmaceutical industry may be losing a heated battle over drug prices
Read MoreGilead fires back at medical journal report critical of its pricing
(By Ed Silverman for ST A T) After getting beaten up last week over the pricing of its hepatitis C
Read MorePharmacy benefit managers are restricting access to lots of drugs next year
(By Ed Silverman for ST A T) I n the latest bid to control prescription drug spending, the nation’s largest
Read MoreThe ‘gouge factor’: Big companies want transparency in drug price negotiations
(By Ed Silverman for ST A T) The path that prescription drugs take from the lab to your medicine chest
Read MoreStudy Bodes Well For Biosimilars But Highlights Need For More Research
(By Sydney Lupkin for Kaiser Health News) Research released Monday finds comparable safety and efficacy for one type of biosimilar
Read MoreWhat instructions? Majority of Americans misuse prescription drugs
(By Ed Silverman for ST A T) M any Americans appear to be misusing their prescription drugs in ways that
Read More